<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0155157</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3696</journal-id>
<journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id>
<journal-id journal-id-type="iso-abbrev">FEBS Lett.</journal-id>
<journal-title-group>
<journal-title>FEBS letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">0014-5793</issn>
<issn pub-type="epub">1873-3468</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28493559</article-id>
<article-id pub-id-type="pmc">5933947</article-id>
<article-id pub-id-type="doi">10.1002/1873-3468.12675</article-id>
<article-id pub-id-type="manuscript">NIHMS962946</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>mTOR referees memory and disease through mRNA repression and competition</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Raab-Graham</surname>
<given-names>Kimberly F.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niere</surname>
<given-names>Farr</given-names>
</name>
</contrib>
<aff id="A1">Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston Salem, NC, USA</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Correspondence K. F. Raab-Graham, Department of Physiology and Pharmacology, Wake Forest School of Medicine, Medical Center, Boulevard, Winston Salem, NC, USA, Fax: 336 716 8501, Tel: 336 716 6072, <email>kraabgra@wakehealth.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>28</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>591</volume>
<issue>11</issue>
<fpage>1540</fpage>
<lpage>1554</lpage>
<!--elocation-id from pubmed: 10.1002/1873-3468.12675-->
<abstract>
<p id="P1">Mammalian target of rapamycin (mTOR) activity is required for memory and is dysregulated in disease. Activation of mTOR promotes protein synthesis; however, new studies are demonstrating that mTOR activity also represses the translation of mRNAs. Almost three decades ago, Kandel and colleagues hypothesised that memory was due to the induction of positive regulators and removal of negative constraints. Are these negative constraints repressed mRNAs that code for proteins that block memory formation? Herein, we will discuss the mRNAs coded by putative memory suppressors, how activation/inactivation of mTOR repress protein expression at the synapse, how mTOR activity regulates RNA binding proteins, mRNA stability, and translation, and what the possible implications of mRNA repression are to memory and neurodegenerative disorders.</p>
</abstract>
<kwd-group>
<kwd>local translation</kwd>
<kwd>mammalian target of rapamycin</kwd>
<kwd>mRNA</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>